tiprankstipranks
Relay Therapeutics (RLAY)
NASDAQ:RLAY
US Market

Relay Therapeutics (RLAY) Technical Analysis

Compare
429 Followers

Technical Sentiment

Overall Consensus
Strong Sell
3Bullish
5Neutral
14Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Relay Therapeutics’s (RLAY) Moving Averages Convergence Divergence (MACD) indicator is -0.16, suggesting Relay Therapeutics is a Buy.
Relay Therapeutics’s (RLAY) 20-Day exponential moving average is 4.20, while Relay Therapeutics’s (RLAY) share price is $4.09, making it a Sell.
Relay Therapeutics’s (RLAY) 50-Day exponential moving average is 4.51, while Relay Therapeutics’s (RLAY) share price is $4.09, making it a Sell.

Relay Therapeutics (RLAY) Pivot Points

Feb 23, 2025, 12:05 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
3.77
3.90
3.99
4.12
4.21
4.34
4.43
Fibonacci
3.90
3.98
4.03
4.12
4.20
4.25
4.34
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Relay Therapeutics (RLAY) Moving Averages

Feb 23, 2025, 12:05 AM
Period
Simple
Exponential
MA5
4.02Sell
4.01Sell
MA10
3.98Sell
4.07Sell
MA20
4.29Sell
4.20Sell
MA50
4.41Sell
4.51Sell
MA100
5.12Sell
5.07Sell
MA200
6.19Sell
6.01Sell
Relay Therapeutics’s (RLAY) 10-Day exponential moving average is 4.07, while Relay Therapeutics’s (RLAY) share price is $4.09, making it a Sell.
Relay Therapeutics’s (RLAY) 100-Day exponential moving average is 5.07, while Relay Therapeutics’s (RLAY) share price is $4.09, making it a Sell.
Relay Therapeutics’s (RLAY) stock price is $4.09 and Relay Therapeutics’s (RLAY) 50-day simple moving average is 4.41, creating a Sell signal.
Relay Therapeutics’s (RLAY) stock price is $4.09 and Relay Therapeutics’s (RLAY) 100-day simple moving average is 5.12, creating a Sell signal.
Relay Therapeutics’s (RLAY) stock price is $4.09 and Relay Therapeutics’s (RLAY) 200-day simple moving average is 6.19, creating a Sell signal.

Relay Therapeutics (RLAY) Technical Indicators

Feb 23, 2025, 12:05 AM
Name
Value
Implied Action
RSI (14)
41.60
Neutral
STOCH (9,6)
47.53
Neutral
STOCHRSI (14)
35.73
Neutral
MACD (12,26)
-0.16
Buy
ADX (14)
15.29
Buy
Williams %R
-75.20
Buy
CCI (14)
-61.12
Neutral
ATR (14)
0.33
-
Ultimate Oscillator
47.91
Neutral
ROC
-12.30
Sell
Relay Therapeutics’s (RLAY) Relative Strength Index (RSI) is 41.60, creating a Neutral signal.
Relay Therapeutics’s (RLAY) Trend Strength Indicator (ADX) is 15.29, creating a Buy signal.
Relay Therapeutics’s (RLAY) Commodity Channel Index (CCI) is -61.12, creating a Neutral signal.
Relay Therapeutics’s (RLAY) Price Rate of Change (ROC) is -12.30, creating a Sell signal.

FAQ

Is RLAY a Buy, Hold, or Sell?
Based on RLAY’s technical indicators, RLAY is a Strong Sell.
    What is RLAY’s RSI (14)?
    RLAY’s RSI (14) is 41.60, which suggests RLAY is a Neutral.
      What is RLAY’s MACD?
      RLAY’s MACD is -0.16, which suggests RLAY is a Buy.
        What is RLAY’s 5-day moving average?
        RLAY’s 5-day moving average is 4.02, which suggests RLAY is a Sell.
          What is RLAY’s 20-day moving average?
          RLAY 20-day moving average is 4.29, which suggests RLAY is a Sell.
            What is RLAY’s 50-day moving average?
            RLAY’s 50-day moving average is 4.41, which suggests RLAY is a Sell.
              What is RLAY’s 200-day moving average?
              RLAY’s 200-day moving average is 6.19, which suggests RLAY is a Sell.
                What is RLAY’s Williams % R (14)?
                RLAY’s Williams % R (14) is -75.20, which suggests RLAY is a Buy.
                  What is RLAY’s CCI (14)?
                  RLAY’s CCI (14) is -61.12, which suggests RLAY is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis